LAUREN KING: Open Payments
NPI 1467807487 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$168 in 9 payments from 9 companies in 2025. Trend: 2023 $526 · 2024 $283 · 2025 $168
Food & beverage: $168
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 1 | $28 |
| Novartis Pharmaceuticals Corporation | 1 | $20 |
| Janssen Biotech, Inc. | 1 | $20 |
| Regeneron Healthcare Solutions, Inc. | 1 | $19 |
| Stemline Therapeutics Inc. | 1 | $18 |
| Acrotech Biopharma Inc. | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| Lilly USA, LLC | 1 | $15 |
| EMD Serono, Inc. | 1 | $15 |
Products named: IMBRUVICA, KISQALI, RYBREVANT, LIBTAYO, Orserdu, BELEODAQ, ENHERTU, VERZENIO.
Industry payments across AL — which companies pay providers there.
